Hydroxychloroquine-induced podocytopathy mimicking Fabry disease

Hydroxychloroquine (HCQ) is largely prescribed as an immunomodulator to prevent systemic diseases flares in patients with systemic lupus erythematous, rheumatoid arthritis, Sjogren’s disease. Among reported side effects, HCQ can accumulate in lysosomes and induced phospholipidosis. Here, we report a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Case Rep
Autors principals: Serre, Justine, Buob, David, Boffa, Jean-Jacques
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2019
Matèries:
Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536225/
https://ncbi.nlm.nih.gov/pubmed/31088818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-228876
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars